Alpha Tau Medical (DRTS) Equity Ratio (2020 - 2025)

Alpha Tau Medical has disclosed Equity Ratio across 6 years of filings, most recently posting 0.73 for Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.73, changed 0.38% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.73 (changed 0.38% YoY), and the FY2025 annual result was 0.73, changed 0.38% from the prior year.
• Equity Ratio came in at 0.73 for Q4 2025 at Alpha Tau Medical, roughly flat from 0.73 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.9 in Q3 2022 to a low of 0.82 in Q4 2021.
• The 5-year median for Equity Ratio is 0.79 (2022), against an average of 0.61.
• Across the five-year window, Equity Ratio tumbled 417.89% in 2021 and surged 206.75% in 2022, its largest moves.
• Alpha Tau Medical's Equity Ratio stood at 0.82 in 2021, then surged by 206.75% to 0.88 in 2022, then declined by 10.55% to 0.79 in 2023, then declined by 7.59% to 0.73 in 2024, then climbed by 0.38% to 0.73 in 2025.
• The last three Equity Ratio figures came in at 0.73 (Q4 2025), 0.73 (Q4 2024), and 0.79 (Q4 2023), per Business Quant data.